Strengths and limitations
cancer, TIDieR
CANCER
To the best of our knowledge, ENGAGE is first trial worldwide designed to test the feasibility of an internet administered, guided, LICBT based, self‐help intervention for parents of children treated for cancer. Robust methods examined a range of feasibility objectives, alongside a priori specified progression criteria. The intervention protocol is published in accordance with TIDieR guidelinesThe study also has limitations. E‐therapists adherence to the intervention was examined by only one licensed clinical psychologist with adherence marked as absent/present. Future studies should develop an intervention adherence checking tool, examining both adherence and quality.